Bemesetron
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171824This classification denotes a 5-ht3 receptor antagonist with the molecular formula C15H17Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O98T3677PA, chemically known as 3-tropanyl-3,5-dichlorobenzoate but generally known as bemesetron, which bears US NIH Compound Identifier 1683. European Medicines Agency schedules Bemesetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05692MIG. The term BEMESETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). BEMESETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bemesetron under HS 29399900 and SITC 54149. As of Q4 2014, BEMESETRON remains the US FDA Preferred Term for this commodity. Bemesetron bears US NLM identifiers UMLS ID C0164151 and NCI Concept Code C80766. SMILES: CLC1CC(C(=O)OC2CC3N(C(CC3)C2)C)CC(CL)C1.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.